However, the Tamil Nadu unit of the Indian Medical Association has asked the government to review the COVID-19 price cap saying it is not feasible for hospitals to maintain it. The first sign was a high fever. And when the coronavirus test results came in two days later, Chennai-based Saminathan …
Read More »India to Leverage Election Skill to Deliver Coronavirus Vaccine
Indian Prime Minister Narendra Modi asked his officials to prepare for a rapid delivery of the Covid-19 vaccine to all citizens of the country using the nation’s experience in conducting elections and management programs. major disasters in the world. The federal government has to collaborate with others, including states and …
Read More »Ailments in covid-19 trials raise questions about vaccine method
Johnson & Johnson said Monday night that it would stop its trial to investigate an illness, which it did not specify, in a study participant. Meanwhile, AstraZeneca Plc’s US trial of the vaccine it is developing with the University of Oxford has been halted by regulators for more than a …
Read More »Crucial next 2.5 months in the fight against coronavirus: Health Minister Harsh Vardhan | India News
NEW DELHI: The next two and a half months will be crucial in the fight against coronavirus due to the winter season and festivals, Union Health Minister Harsh Vardhan said on Friday. Vardhan, who is also Minister of Science and Technology, said that three candidate vaccines are progressing well in …
Read More »Government identifies 30 million rupees to receive vaccine with priority
(This story was first published in The Times Of India on October 17, 2020) New Delhi : As the world prepares for a Covid-19 vaccine, India has begun to identify around 30 million priority beneficiaries, including the high-risk population and first responders, from healthcare workers to police, workers sanitation workers, …
Read More »No major mutation in coronavirus in India will not affect vaccines: Center
The coronavirus mutation could accelerate the transmission of the disease in some cases. (Proceedings) New Delhi: Two studies on the coronavirus genome in India by the country’s main clinical research body and the Department of Biotechnology suggest that the COVID-19 virus is genetically stable and has not shown any major …
Read More »Vaccine ready for December, on the market for March: Serum Institute reveals Covid-19 vaccine planning
India will receive 60-70 million doses of the Covishield vaccine from Oxford by December, but the vaccines will hit the market in March 2021, the Serum Institute of India (SII) in Pune said, revealing its latest updates on the ongoing trial of the Astrazeneca-Oxford vaccine. Time between December and March …
Read More »Covid-19 Vaccine: Sputnik V To Be Tested In India, Dr. Reddy Gets DCGI Approval
After rejecting the first proposal, India’s General Drug Controller finally allowed Dr. Reddy’s to conduct a phase 2/3 human clinical trial of Sputnik V, the Covid-19 vaccine that makes Russia the first country in develop a vaccine. “This will be a multicentre, randomized controlled study, including a safety and immunogenicity …
Read More »After Sputnik V, Russia Approves Second Covid-19 EpiVacCorona Vaccine; Putin says the third is almost ready
Moscow: Russia has given regulatory approval to a second Covid-19 vaccine, called ‘EpiVacCorona’, after early-stage studies. The new coronavirus vaccine comes two months after a similar move for Russia’s first vaccine, Sputnik V, drew widespread criticism from scientists both at home and abroad. Also Read – Latest COVID-19 Vaccine Update: …
Read More »Covid-19 vaccine: healthy young people may have to wait until 2022, says WHO
The wait for the Covid-19 vaccine may be longer for the young population in good health, said World Health Organization chief scientist Dr. Soumya Swaminathan at a WHO social media event. . “Most people agree, it’s starting with healthcare workers and front-line workers, but even there, you need to define …
Read More »